Attach a copy of patient's ID (.jpg, .pdf, .doc, .docx – less than 10 MB in size):

0%

EVENTS & ACHIEVEMENTS

EVENTS & ACHIEVEMENTS
Clemenceau Medical Center Named as Center of Excellence in Customer Service in IMTJ Medical Travel Awards 2016 (30/05/2016)

Clemenceau Medical Center, Beirut wins major international award

Clemenceau Medical Centernamed as center of excellence in customer service in IMTJ Medical Travel Awards 2016

Clemenceau Medical Center has won a major international medical tourism award for their efforts in attracting international patients to Beirut, Lebanon. 

Clemenceau Medical Center were named as center of excellence in customer service by medical travel publication the International Medical Travel Journal Medical Travel Awards 2016 (http://awards.imtj.com) at their annual awards ceremony.

The awards were presented on 24th May at a high profile reception in Madrid during the International Medical Travel Journal Medical Travel Summit, which brought together all the pre-eminent providers and experts in medical travel and medical tourism sectors. The Awards were generously supported by the Tourism Association of Madrid and Spaincares.


The award was given to Clemenceau Medical Center in recognition of their excellence in customer service. Clemenceau Medical Center beat similar businesses/clinics from around the world to clinch the award.


Dr. Mounes Kalaawi, Chief Executive Officer of Clemenceau Medical Center stated “Today CMC’s commitment to service excellence is recognised once again and exceeded all expectations. The IMTJ Medical Travel Award is a recognition to the hard work, professionalism and dedication to excellence in customer care that we developed in this hospital since its opening through implementing the hospitality services, providing a 5 stars environment to its customers; exceeding their expectations and increasing their satisfaction. CMC is continuously looking to improve its standards and raise the bar to higher level “.


Chairman of the judging panel and Managing Editor of IMTJ Keith Pollard says the awards celebrate the best providers in the industry and aim to encourage others to strive to match them:

“Medical travel is an exciting and growing global industry, with many providers delivering excellence in both medical care and customer service. The IMTJ Medical Travel Awards are the only independent awards to recognise those who are the best of the best - and hopefully will encourage others to emulate their success. The judges wanted to reward innovation and excellence, highlight best practice and celebrate those who are leading the way in the industry and delivering successful outcomes for patients.


“All our winners exemplify the way the medical tourism industry should be run – professional, offering exceptional patient care and providing the best possible medical outcomes. I’m already looking forward to next year’s awards in the hope that other clinics and companies will have raised their game to match or even better this year’s winners.”


ENDS

 

About IMTJ

The International Medical Travel Journal ( www.imtj.com) provides insight into the medical travel and medical tourism sector. IMTJ was established in 2007 in response to the increasing interest in medical travel and medical tourism. It embraces many of the themes that challenge healthcare providers across the world – insurance, accreditation, marketing and promotion, quality, patient safety, levels of care and experience in treating international patients.

IMTJ is independent of the associations and special interest groups that have come aboard the medical tourism bandwagon. Our aim is to create a central focus for information, resources and opinion on medical travel for those involved in the industry, anywhere in the world.

The internationalisation of healthcare through health tourism is at the heart of IMTJ. Patients are becoming healthcare consumers and in many countries, patient choice is being extended to surgery and treatment provided by international hospitals and clinics. By sharing expertise, knowledge, and views about the health travel industry, IMTJ helps to ensure that patient expectations are met, and that the industry maintains a high reputation.

The International Medical Travel Journal (IMTJ) is owned and managed by Intuition Communication, a specialist publisher of consumer and business-to-business information on private healthcare and medical travel.  The company also operates a consumer facing portal for medical tourism – Treatment Abroad.
 

Clemenceau Medical Center Brings News of Multi-Treatment Approach on Cancer to the Middle East (30/10/2015)

Every year, more than 145,000 people die in the Middle East as a result of cancer, according to global statistics collected by the American Cancer Society. If detected early, more than one-third of those deaths are easily preventable or treatable.
In order to discuss the latest trends and discoveries to treat lung, colorectal and breast cancers, as well as pain management, physicians from around the region gathered on Oct. 30-31, 2015, in the third annual Cancer Care Forum hosted by Clemenceau Medical Center, in affiliation with Johns Hopkins Medicine International, in Beirut, Lebanon.
The theme for this year’s symposium— Integrating New Radiotherapy Procedures in the Multimodality Management of Cancer—explores the benefits of combining more than one method of treatment when managing different types of cancer.

“The rising prevalence of cancer in the Middle East makes this gathering relevant to physicians and students alike,” said Dr. Mounes Kalaawi, CEO of Clemenceau Medical Center. “Having the opportunity to come together and confer on this important topic will help us advance care in the region.” Professor Marwan Ghosn, Director of CMC Cancer Department, added, “We are confident that connecting the different healthcare providers involved in the prevention, diagnosis, treatment and follow-up of oncology patients will bridge the gap between them and contribute to the improvement of cancer patients’ management.”

International speakers from USA, Turkey, and France, included two Johns Hopkins Medicine faculty. Dr. Phuoc T. Tran, clinical director of radiation oncology and molecular radiation sciences discussed new approaches to treatment of oligometastatic disease and lung cancer. Dr. Jean Wright, associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine, shared insights on post mastectomy radiation treatments and management of breast cancer. Moreover, Dr. Serdar Turhal, President of European Union of Medical Specialists, Oncology Section and Oncologist at Anadolu Medical Center affiliated with Johns Hopkins Medicine International in Istanbul, Turkey, highlighted the importance of regional collaborations in Oncology. Lastly, Dr. Olivier Dubreuil, medical Oncologist specialized in Gastro-Intestinal Oncology at at Pitié - Salpetrière Hospital in Paris, discussed in depth the indications and outcomes of Radioemobilization.

The Cancer Care Forum was the ideal platform to address current topics in Radiation Therapy as CMC prepares to open its new comprehensive Cancer Center with a specialized state-of-the-art Radiation Therapy unit in 2016. The unit, headed by Dr. Nicolas G. Zouain, will be the first in Lebanon and the region to install a new, state-of-the-art, image-guided technology that provides more accurate, concentrated doses of radiation. CMC has teamed up with Varian® and Brainlab®, the leading companies in the field of Radiation Oncology, to build the most advanced radiation oncology facility in the Middle East. The department will feature advanced procedures such as: Stereotactic Body Radiation Therapy (SBRT), Sterotactic Radiosurgery (SRS), Stereotactic Radiation Therapy (SRT), and Intensity-Modulated Radiation Therapy (IMRT).

Clemenceau Medical Center, one of the top private hospitals in Lebanon, and Johns Hopkins Medicine International, the global arm of Johns Hopkins Medicine, have been affiliated since 2006. Through their collaboration, the two organizations have developed different clinical programs, supported all three Joint Commission International reaccreditation processes and strengthened capacity by providing lectures, workshops, seminars and conferences on site covering the topics of gastroenterology, cardiology, oncology, orthopedics, women’s health, internal medicine and nursing leadership, among others.

An Unprecedented Accomplishment: TAVI Procedure on Oldest Lebanese Patient at Clemenceau Medical Center (21/10/2015)

The cardiovascular team, composed of Dr. Omar Hamoui, Dr. Labib AbuDaher, Dr. Wael Jaroudi, and Dr. Omar Itani, at Clemenceau Medical Center successfully performed a life-saving and unprecedented heart procedure on a 92-year-old female patient on July 7th 2015. She is the oldest patient in Lebanon to have received a trans-catheter aortic valve implantation (TAVI).

The semi-invasive TAVI procedure uses the catheterization approach to replace a severely calcified or narrowed aortic valve, eliminating the need for open-heart surgery. For patients with conditions rendering them unable to undergo open-heart surgery TAVI is an effective alternative to replace the valve with proven survival benefit. It also improves the quality of life.

“Our 92-year-old patient had severe emphysematous lung disease and could not undergo surgery. Prior to her TAVI procedure she was getting hospitalized for pulmonary edema on an almost weekly basis and required powerful, dangerous medications,” said Dr. Omar Hamoui. “ After the TAVI procedure, she had a very good recovery, and was discharged home on day four. It has been more than two months since her discharge and she has not needed any additional hospitalizations. Her breathing is now normal.”

On a global scale, the TAVI procedure has proven to be an effective therapeutic alternative to conventional surgery in the treatment of severe aortic valve disease. Severe aortic stenosis is a critical condition that leads to heart failure and death if not treated. Most of the patients diagnosed with this ailment are elderly and often have comorbid conditions.

The cardiovascular team at CMC responsible for the unprecedented procedure on such an elderly patient is composed of an interventional cardiologist, a cardio-thoracic surgeon, an imaging cardiologist, a cardiac anesthesiologist, and cardiac nurses/ technicians.

Clemenceau Medical Center Hosts Gastroenterology Symposium on Integrative Medicine (23/09/2015)

Clemenceau Medical Center, in affiliation with Johns Hopkins Medicine International, announced its third annual Gastroenterology Symposium that was held on Sept. 17, 2015, in Beirut, Lebanon. Physicians from around the region gathered to discuss the latest trends and discoveries in gastroenterology, including new treatments for hepatitis C, improved understanding of gluten sensitivity and allergy, and enhanced dietary and supplement advice for patients with liver disease. The theme for this year’s symposium—From traditional therapies to state-of-the-art biomedicine: Evidence to Practice—highlighted the importance of preventive health and the latest treatments designed to produce the best patient outcomes.


“Gatherings like this one are an important forum for physicians to learn from each other by sharing research, best practices and conferring about trends we are seeing in our practice,” says Dr. Kalaawi, CEO of Clemenceau Medical Center. “The takeaways will help us advance care in the region.”


Three Johns Hopkins Medicine faculty based in Baltimore, USA, travelled to Beirut to present at the continuing medical education credited event. Linda Lee, M.D., founder and director of Johns Hopkins Integrative Medicine and Digestive Center and clinical director of the division of gastroenterology and hepatology, discussed how milk thistle and its derivatives are used to treat liver disease, and how to distinguish gluten sensitivity from gluten allergy and recognize their clinical manifestations. Zhiping Li, M.D., director of hepatology at the Johns Hopkins School of Medicine, and associate professor of medicine, covered the epidemiology of fatty liver disease and its impact to health, new techniques for screening for and treating hepatitis C, and diagnosing autoimmune hepatitis. Mark Lazarev, M.D., assistant professor of medicine, shared insight on available medications, nutrition guidelines and health issues of patients with inflammatory bowel disease.


“This year’s symposium addressed topics and common digestive disorders that are of interest to both physicians and patients,” Ammar Ghazale, M.D., ‎a gastroenterologist and interventional endoscopist at Clemenceau Medical Center. “We believe educating patients about their disorders and therapies helps them take an active role in improving their quality of life.”
Clemenceau Medical Center, one of the top private hospitals in Lebanon and the region, and Johns Hopkins Medicine International, the global arm of Johns Hopkins Medicine, have been affiliated since 2002 (years before its inauguration) . Through their collaboration, the two organizations have developed different clinical programs, supported all three Joint Commission International reaccreditation processes and strengthened capacity by providing lectures, workshops, seminars and conferences on site covering the topics of gastroenterology, cardiology, oncology, orthopedics, women’s health, internal medicine and nursing leadership, among others.

Clemenceau Medical Center in collaboration with City Centre Beirut activates “Feel the Beat” to Increase Awareness about Heart Disease in Women (15/06/2015)

To raise awareness about women’s heart problems and diseases, City Centre Beirut launched an in mall activity under the title of “Feel the Beat” in collaboration with Clemenceau Medical Center CMC affiliated with Johns Hopkins International, a medical center with the most innovative treatments and technologies in the region .

For the third consecutive year, City Centre Beirut took the lead to invite women of all ages to be more aware about the numerous cardiovascular diseases that highly affect women, get their hearts health checked and tune in to a healthy lifestyle.

Commenting on this occasion, Sleiman Mallat, Senior Mall Manager at City Centre Beirut stated: "For the past three years, City Centre Beirut has shown its commitment to its community through raising awareness about an important cause which is women’s health.” He added, Through “Feel the Beat” activation, not only did we help women become more informed about this serious issue, but also gave them the chance to have preventive tests on the spot, with tips on how to maintain a healthy lifestyle.”

About this event, Dr. Mounes Kalaawi , Chief Executive Officer at Clemenceau Medical Center stated: “Its great opportunity to reach the community to perform health awareness, a healthy lifestyle and recommendations to make smart choices that benefit the heart and overall health and to reduce the risks of occurring the chronic disease especially the cardiovascular, which affect a large number of the population worldwide.”

Over the course of 2 days; June 11th and June 12th, women were invited to perform a series of free tests that can prevent or detect potential heart disease. These tests that included blood pressure and blood sugar tests, Body composition/ BMI and Heart saver training/ CPR were performed by a specialized team of Physicians, senior Dietician and Registered Nurses from CMC

About the Clemenceau Medical Center
Clemenceau Medical Center (CMC) (http://www.cmc.com.lb), established in 2006 and affiliated with Johns Hopkins Medicine International, is a state-of-the-art medical center in the heart of Beirut, Lebanon. CMC is JCI accredited and is capable of delivering high-quality health care services in a timely, cost-efficient and pleasant environment to patients from Lebanon and the Middle East. Its mission being “Caring, Safety, Excellence”, Clemenceau Medical Center has established centers of excellence in several specialties, including imaging and laboratory services, cardiology and cardiothoracic surgery, oncology, digestive and liver diseases, neurosurgery, and minimally invasive, robotic and colorectal surgery. CMC houses all specialty branches and is fully equipped with the most advanced medical technology.

CMC First Spine Summit in collaboration with Johns Hopkins Medicine International (22/05/2015)

Clemenceau Medical Center (CMC), affiliated with Johns Hopkins International, held its first Spine Summit at its premises on May 22nd and May 23rd 2015. The event, also held in collaboration with the Lebanese American University (LAU), was attended by many guests and attracted renowned local and international specialists who provided the latest updates on spinal surgery and complications, including degenerative cervical spine, degenerative lumber spine, spinal Infections, spinal deformity, spinal trauma, and spinal oncology.

CEO of Clemenceau Medical Center, Dr. Mounes Kalaawi stated: “Hosting the first Spine Summit in Lebanon, in collaboration with Johns Hopkins Medicine International, was a real honor for Clemenceau Medical Center. The event’s great success confirmed CMC’s importance and role within the Lebanese and international healthcare system as well as its commitment to be a leader in terms in continuous education. We believe that the best way to deliver world class healthcare to our patients and stay at the forefront of new techniques is to allow exchange of knowledge between the best specialists in the world through such events.”

Keynote speakers and experts from major universities and medical centers in Lebanon, the Middle East and John Hopkins took part in the summit. Among them were Dr. Youssef Comair, Dr. Mohammad Badra, Dr. Nizar Natout, Dr. Khalil Kharrat, Dr. Chahine Assi, Dr. Ibrahim Saikali; and from Johns Hopkins, Dr. Ali Bydon, Dr. Timothy F. Witham, Dr. Khaled M. Kebaish, and Dr. George I. Jallo. The event was also attended by key opinion leaders and members of the press.

Activity Director and Orthopedic Surgeon, Dr. Mohammad Badra, affirmed: “This summit offers attendees two days of focused discussion and opportunities to advance spinal cord medicine and health care from top experts and specialists. Our goal is to provide attendees with the most updated and vital information that can be put to immediate use to improve the care of the SCI/D patients”.

CMC’s Spine Summit is a platform that gives physicians and experts from different countries the opportunity to exchange knowledge and expertise about the most advanced surgical techniques and technologies related to spinal conditions and diseases. The creation of the summit goes hand in hand with CMC’s mission to offer avant-garde treatments and technologies to patients from Lebanon and the Middle East. CMC is an ultra-modern medical institution fully equipped with the most advanced technology, recognized as one of the top hospitals in the Middle East.

Clemenceau Medical Center tops the list of nominations for the Building Healthcare Awards 2015 (20/05/2015)

Clemenceau Medical Center (CMC) again tops the list of nominations for the Building Healthcare Awards 2015

Clemenceau Medical Center (CMC) has once again been shortlisted for several prestigious awards at the annual Building Healthcare Middle East Exhibition & Conference 2015, formerly known as Hospital Build & Infrastructure Middle East Exhibition & Congress.

Shortlisted nominees come from UAE, Qatar, Lebanon, and Saudi Arabia and were chosen from more than 100 nominees who have excelled in the region's hospital build and infrastructure sector.

Always a top contender, CMC, affiliated with Johns Hopkins International, is the front runner in the shortlist of Middle East healthcare facilities, nominated for 5 out of the 8 categories: Best Physical Environment Award, Best Healing Environment Award, Best Laboratory Design Award, Best Technology Initiative Award, and Best Facilities Management Service Strategy Award.

“Witnessing CMC being nominated, not only across several categories, but also year after year, showcases what can be achieved when high-quality design is coupled with highly effective healthcare delivery- the core and underlying principle of the CMC concept,” commented Dr. Mounes Kalaawi, CEO of Clemenceau Medical Center.

The Building Healthcare Exhibition & Conferences recognizes excellence in the design, operation and management of healthcare facilities in the Middle East. It also provides a platform on which to discuss new healthcare projects, share best practice in design and construction, and source technologies and services that will maximize facility operations and improve patient experience.

The winners will be announced at the Building Healthcare Middle East Exhibition & Conferences on the 9th of June 2015 at the Dubai International Convention & Exhibition Centre.

First in Lebanon to Treat Inoperable Liver Tumors via Interventional Radiology (26/01/2015)

Using Interventional Radiology to Treat Cancer
Interventional radiology (IR) offers innovative, non-surgical treatment options to patients with a wide variety of conditions and diseases, including cancer. Using minimally-invasive techniques under imaging guidance, interventional radiologists are uniquely skilled in delivering precision-targeted therapy to malignancies in virtually any part of the body.

One of the most exciting IR developments is a technique called radioembolization. At Clemenceau Medical Center, we are excited to report that our Interventional Radiologist Dr. Kabalane Yammine has performed the first three cases in Lebanon to treat liver tumors that are inoperable. Clemenceau Medical Center is the only medical center in Lebanon using this novel approach.

Big Hope in Small Package
Radioembolization is an outpatient procedure that delivers radiation directly to the tumor site. Interventional radiologists use a catheter to place millions of microspheres—minute particles that emit radiation—into the blood vessels, or capillaries, feeding the tumor(s). The microspheres become trapped, cutting off of the tumor(s) blood supply and destroying malignant cells that are inaccessible by other techniques.

Why Radioembolization for Primary and Metastatic Liver Tumors?
In addition to being an excellent option for patients with inoperable primary and metastatic liver tumors, radioembolization can be used in conjunction with other treatment modalities, such as chemotherapy, and as a bridging technique prior to radiofrequency ablation, surgery or transplantation.

This highly localized technique addresses the challenges commonly associated with other cancer treatments by delivering radiation only to where it is needed. Healthy liver tissue remains relatively unaffected, and patients rarely experience fatigue, nausea or vomiting.

Radioembolization is bringing new hope for greater survival to people with primary and metastatic liver cancer. It is also enhancing the quality of life for these patients by minimizing therapy-related discomfort, recovery time and side effects.

Clemenceau Medical Center (CMC) (http://www.cmc.com.lb), established in 2006 and affiliated with Johns Hopkins Medicine International, is a state-of-the-art medical center in the heart of Beirut, Lebanon. CMC is JCI accredited and is capable of delivering high-quality health care services in a timely, cost-efficient and pleasant environment to patients from Lebanon and the Middle East. Its mission being “Caring, Safety, Excellence”, Clemenceau Medical Center has established centers of excellence in several specialties, including imaging and laboratory services, cardiology and cardiothoracic surgery, oncology, digestive and liver diseases, neurosurgery, and minimally invasive, robotic and colorectal surgery. CMC houses all specialty branches and is fully equipped with the most advanced medical technology.

Clemenceau Medical Center is accredited for the third time from Joint Commission International (19/01/2015)

Clemenceau Medical Center in affiliation with Johns Hopkins International has been accredited for the third time after three years from its Joint Commission International (JCI) Re-accreditation in 2012. Accreditation and certification are granted to health care organizations that meet a set of standard requirements designed to improve quality of care. CMC was 99.6% compliant with the 285 standard requirements of the 1160 Measurable elements set by JCI Reaccreditation.


“This was not a good report, that was an excellent report” said Robert Christmas, team leader of JCI surveyor team. “We are leaving CMC carrying with us hundreds of best practices that can be shared with other institutes worldwide” added the JCI surveyor team.


Dr. Mounes Kalaawi, Chief Executive Officer of CMC hospital stated:” Clemenceau Medical Center Accreditation for the third time by JCI is an outstanding achievement for Lebanon and the region.
Today CMC’s commitment to quality and service excellence once again is recognized and exceeded all expectations.
I am sure that maintaining our JCI Accreditation for the third time is a testament to the hard work, professionalism and commitment to excellence in patient care that we developed in this hospital over the last 10 years. CMC is continuously raising healthcare quality and standards to higher level “.

The Joint Commission International (JCI) works to improve patient safety and quality of health care in the International community by offering international accreditation and certification as well as through advisory and educational services in order to promote rigorous standards of care and to provide solutions for achieving peak performance.
 

Second Cancer Care Forum 2014 in collaboration with Johns Hopkins Medicine International (17/10/2014)

Clemenceau Medical Center (CMC), affiliated with Johns Hopkins International, held for the second year in a row the Cancer Care Forum on the 17th and 18th of November 2014.
The forum was a success. Attended by hundreds of guests, it attracted local, regional and international multi-disciplinary specialists who presented lectures covering topics related to the care of cancer patients including, screening for cancer, prevention, research, quality, multidisciplinary approach and latest treatment modalities.

Dr. Mounes Kalaawi, Chief Executive Officer at CMC said “It is our honor to host the Second Cancer Care Forum in collaboration with Johns Hopkins Medicine International confirming CMC’s commitment to be at the forefront of healthcare innovation in Lebanon and the region, bringing forward a multitude of knowledge and experience.” He added “Local, regional and international patients deserve the best quality of care and CMC will always aim to provide the world class healthcare through continuous education to its team”.

Keynote speakers from reputable Universities in Lebanon, the Region and John Hopkins were present in the conference. Among them, were Dr. Ali Bydon, MD, MSc, Associate Professor of Neurosurgery at Johns Hopkins University, Dr. Naji Khouri, MD, Radiology & Oncology for Johns Hopkins International, Dr. Ronan Kelly, MD, MBA, Medical Director of Global Oncology for Johns Hopkins International, Dr. Sami Khatib, MD, from Jordan and Dr. Hamdy Azim, MD, MSc, Chairman of Oncology Department at Cairo University.

Professor Marwan Ghosn, Director of the Cancer Center at CMC and Chairman of the Forum, summarized the key topics discussed during the meeting:
“Currently available chemotherapy kills normal cells as well as cancer cells, leading to serious side effects. The immune system, meanwhile, is remarkably effective at combating bacterial and viral invaders while sparing normal cells, but the goal of coaxing immune cells to target cancer has eluded researchers for decades. The new frontier in cancer treatment is getting a person’s own immune system to eliminate tumors, rather than targeting the cancer cells with chemotherapy. In contrast to conventional cancer treatments, Immunotherapies can lead to very durable clinical responses. Novel agents, including checkpoint inhibitors such as anti-PD-1 antibody, anti-PD-L1 antibody and CTLA-4 inhibitors are being developed. Positive results were observed.”

Progress in the management of Spinal tumors by advanced surgical techniques and stereotactic or cyber knife radiotherapy were exposed.
In addition, Lung Cancer occupied a big part of the discussion focusing on the extremely promising results of immunotherapy in this disease and highlighting the minimally invasive new procedure in the evaluation of these tumors (Endobronchial ultrasound - EBUS).


Palliative care took an important place of the forum. Myths and taboos in cancer care in Middle East Countries were reviewed.
Finally, “Simulation” an innovative, a method to train practicing nurses and other health care professionals on new procedures and healthcare techniques was highlighted. Its major role to generate better quality in the management and support of the patients were exposed.

Medical tourism milestone for Lebanon as Clemenceau Medical Center becomes first hospital to receive international certification (05/09/2014)

Beirut’s Clemenceau Medical Center affiliated with Johns Hopkins International achieves medical tourism certification for excellence in quality of care and services for medical travelers by the Medical Travel Quality Alliance.

September 5, 2014 – Beirut and Scottsdale – Clemenceau Medical Center affiliated with Johns Hopkins International, as one of the world’s best hospitals for medical tourists, has become the first hospital in Lebanon to achieve international medical tourism certification from the US-based Medical Travel Quality Alliance.

“We are thrilled to be able to award medical tourism certification to such an outstanding hospital. After a review of its operations and processes for care and services to medical tourists, our evaluators have determined that it offers excellent and upstanding services to the international patients and medical travelers that seek care at Clemenceau,” announced Julie Munro, President of MTQUA.

Medical tourism certification is awarded to a hospital, clinic or medical tourism agency that meets the international standard of quality in 10 non-clinical areas that directly impact a medical tourist’s well-being and good results.

“Achieving certification is a great pride. It puts Lebanon in the top niche as a world's leading destination for international patients" said Dr. Mounes Kalaawi, CEO of Clemenceau Medical Center. By providing a strong foundation of quality, in all our patient care processes we have delivered exceptional value to both our Lebanese, regional and international patients. We fulfilled our mission which is “caring safety, excellence”.
He added: “This certification comes after we have achieved further distinctions in patient satisfaction. Our strategic aims at positioning Clemenceau Hospital Center as the first choice not only for local patients but also for all the patients in the world seeking excellence in the medical care, the best medical knowledge and experience, the best technology available”.

Seal displayed by medical tourism certified hospitals, clinics and agencies.
The MTQUA evaluation team reviewed how the hospital manages a medical tourist including the inquiry process, intake procedure, and care management after discharge. They studied the hospital’s website and internet marketing, communication procedures, privacy and security measures, multicultural sensitivity, International Patient Services department, care support services and certain operations and business procedures that influence the quality of treatment and care a medical tourist receives.

“Medical tourists are not ordinary patients,” said Ms. Munro. “They need more attention, not only in matters of comfort but more important, in matters of care. They want to know that they can trust the hospital or the agency to deliver on what they promise. We are confident they will get all of this from My Medical Vacations.”

CMC- an authorized American Heart Association (AHA) International Training Center (ITC) for life saving CPR and first aid training (06/08/2014)

Clemenceau Medical Center has been officially recognized as an American Heart Association (AHA) International Training Center (ITC) for life saving CPR and first aid training.

AHA is the oldest and largest established voluntary organization devoted to fighting cardiovascular diseases and strokes in the world; it is a professional body approved by Joint Commission International Accreditation (JCIA ) for all life saving CPR and first aid training.

CMC among the 30 Most Technologically Advanced Hospitals in the World (16/06/2014)

Clemenceau Medical Center (CMC), affiliated with Johns Hopkins International was selected among the “30 Most Technologically Advanced Hospitals in the World” by Master’s in Healthcare Administration - MHA 2014 (http://www.topmastersinhealthcare.com/30-most-technologically-advanced-hospitals-in-the-world/). CMC was chosen among hospitals across the globe with high-tech medical care and state-of-the art equipment. The hospital was recognized as one of the most technologically advanced hospitals in the world for seeking excellence in medical care, the best medical knowledge and experience, the best technology available.

This ranking comes in recognition of CMC’s continuous efforts to establish an internationally renowned reputation in the medical sector.
Completed in 2005, CMC is an ultra-modern medical institution fully equipped with the most advanced technology, recognized as one of the top hospitals in the Middle East.
CMC is the first facility in Lebanon and the region that provides a multi-disciplinary Robotic surgery program. CMC patients are among the first to benefit from avant -garde treatments & technologies.

“We at CMC are extremely proud to be identified as one of the leading health care institutions in the world” said Dr. Mounes Kalaawi, CEO of Clemenceau Medical Center. “The services at CMC have been designed around the needs of patients to enhance the quality of care and speed-up diagnosis and treatment. Our ultimate aim remains to improve the patient experience by providing the best of the world to our patients in Lebanon and the region” he added.

Middle East Hospital Build & Infrastructure Exhibition & Congress (02/06/2014)

Clemenceau Medical Center (CMC) wins award for Best Facilities Management Service Strategy at Middle East Hospital Build & Infrastructure Exhibition & Congress 2014


CMC has won the “Best Facilities Management Service Strategy” award at the awards ceremony during Hospital Build & Infrastructure Exhibition & Congress, held in Dubai on June 2, 2014 to recognize outstanding healthcare facilities in the Middle East. The hospital has also been highly commended for “Best Hospital Design”, “Best Physical Environment”, “Best Laboratory Design” and “Best Healing Environment” awards.

‘Best Facilities Management Service Strategy Award’ is a newly introduced category granted for outstanding healthcare service providers who have demonstrated excellence in the provision of a facilities management strategy that embraces the widest possible scope of services, meeting the needs of the clinical teams and improving patient safety.

“What an honor to be recognized this year again, by regional and international leaders in the healthcare sector,” commented Dr. Mounes Kalaawi, CEO of Clemenceau Medical Center, who, in his thank you note to the team wrote “Once again this year, your commitment to quality and service excellence is recognized beyond our organization, at the hospital build Dubai. I am proud as you all should be, thanks to your hard work, commitment and loyalty.”

Arab Health Achievement & Innovation Awards (27/01/2014)

Clemenceau Medical Center, affiliated with Johns Hopkins International, shortlisted for 2 prestigious awards

Clemenceau Medical Center (CMC), affiliated with Johns Hopkins International, has once again been shortlisted for two awards at the 2014 Arab Health Achievement and Innovation Awards; the Roche Excellence in Laboratory Award and the Excellence in Patient Centered Care Award. The awards recognize individuals, hospitals, departments, teams or organizations that contribute to the growth and development of the healthcare industry throughout the Middle East.

Roche Excellence in Laboratory Award is presented to the organization or department that has made the greatest contribution in the field of medical laboratory. The criteria for selection are based on evidence of true positive results; safety within the laboratory; waste management policy and blood management policy; Patient identification; innovation and continuous improvement.
The Excellence in Patient Centered Care Award is presented to the hospital or institution that has developed the most effective patient centered care approach in the region. As for the criteria for selection, it encloses initiatives implemented to make the hospital or institution more patients friendly; initiatives implemented to educate patients; evidence of increasing patient satisfaction; patient privacy and patient rights.